GPCR – structure therapeutics inc. (US:NASDAQ)
Stock Stats
News
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $91.00 price target on the stock.
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights [Yahoo! Finance]
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Form 10-Q Structure Therapeutics For: Mar 31
Form 8-K Structure Therapeutics For: May 09
Form ARS Structure Therapeutics For: Dec 31
Form DEF 14A Structure Therapeutics For: Jun 25
Form 4 Structure Therapeutics For: Apr 17 Filed by: FMR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.